Showing results (411-420 of 419) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 419 results.
Journal of Neuro-Oncology|September 4, 2024
Frailty indices predict mortality, complications and functional improvements in supratentorial meningioma patients over 80 years of ageChristoph Schwartz, Moritz F Ueberschaer, Ilari Rautalin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205Rimas V Lukas, Lijie Zhai, Kristen L Lauing, et al.
The Journal of Clinical Investigation|May 29, 2014
Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progressionRoberto Ferrarese, Griffith R Harsh, Ajay K Yadav, et al.
Neuro-Oncology|January 26, 2026
Integrated immune profiling of chordomas reveals spatially organized niches and functional heterogeneityVictor A Arrieta, J Kada Benotmane, Rebecca Du, et al.
The Lancet. Oncology|September 4, 2025
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysisKarenna J Groff, Ruchit V Patel, Yang Feng, et al.
Nature Communications|February 12, 2026
STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathwaysMark W Youngblood, Shashwat Tripathi, Hinda Najem, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric GliomasMaria B Garcia-Fabiani, Santiago Haase, Kaushik Banerjee, et al.
Nature Medicine|November 9, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesWilliam C Chen, Abrar Choudhury, Mark W Youngblood, et al.
Pageof 42